Two heart failure therapies prove to be nearly identical in reducing death

In a head-to-head comparison of two so-called 'water pills' that keep fluid from building up in patients with heart failure, the therapies proved nearly identical in reducing deaths, according to a large study led by Duke Health researchers.

Related Keywords

Chicago ,Illinois ,United States ,American ,Kevinj Anstrom ,Ericj Velazquez ,Vandana Sachdev ,Amandah Harrington ,Dong Yun Kim ,Patrice Desvigne Nickens ,Jeffreym Testani ,Stephenj Greene ,Robertj Mentz ,Emily Henderson ,Shelby Morgan ,Fassil Ketema ,Ericl Eisenstein ,Bertram Pitt ,Shelly Sapp ,Duke Health ,American Heart Association ,Lab Diagnostics Automation ,Duke Clinical Research Institute ,Lab Diagnostics Automation Industry ,National Heart ,Blood Institute ,Duke University School ,Duke Clinical Research ,Automation Industry Focus ,Heart ,Heart Failure ,Clarity ,Furosemide ,Hospital ,